Reversible and non-competitive antagonist profile of CPCCOEt at the human type 1α metabotropic glutamate receptor

被引:47
|
作者
Hermans, E [1 ]
Nahorski, SR [1 ]
Challiss, RAJ [1 ]
机构
[1] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England
基金
英国惠康基金;
关键词
glutamate; mGlu1 alpha receptor; phosphoinositide hydrolysis; non-competitive antagonist; CPCCOEt;
D O I
10.1016/S0028-3908(98)00132-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In transfected CHO cells expressing the human metabotropic glutamate receptor mGlu1 alpha, 7- hydroxyimino)cyclopropan[b]chromen-1a-carboxylic acid ethylester (CPCCOEt) was found to antagonize L-quisqualate-induced phosphoinositide hydrolysis in a non-competitive and reversible manner (apparent pK(i) value, 4.76 +/- 0.18: It = 3. This suggests that CPCCOEt antagonizes type Ir metabotropic glutamate receptor activation by interacting with a site distinct from the agonist binding site. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1645 / 1647
页数:3
相关论文
共 50 条
  • [1] The non-competitive metabotropic glutamate receptor-1 antagonist CPCCOEt inhibits the in vitro growth of human melanoma
    Haas, Helga Susanne
    Pfragner, Roswitha
    Siegl, Veronika
    Ingolic, Elisabeth
    Heintz, Elfgard
    Schraml, Elisabeth
    Schauenstein, Konrad
    ONCOLOGY REPORTS, 2007, 17 (06) : 1399 - 1404
  • [2] CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding
    Litschig, S
    Gasparini, F
    Rueegg, D
    Stoehr, N
    Flor, PJ
    Vranesic, I
    Prezeau, L
    Pin, JP
    Thomsen, C
    Kuhn, R
    MOLECULAR PHARMACOLOGY, 1999, 55 (03) : 453 - 461
  • [3] Non-competitive inhibitors of metabotropic glutamate receptor 5 (mGluR5)
    Tasler, S
    Kraus, M
    Pegoraro, S
    Aschenbrenner, A
    Poggesi, E
    Testa, R
    Motta, G
    Leonardi, A
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (11) : 2876 - 2880
  • [4] Non-competitive metabotropic glutamate subtype 5 receptor antagonist (SIB-1893) decreases body temperature in rats
    Luszczki, JJ
    Borowicz, KK
    Czuczwar, SJ
    PHARMACOLOGICAL REPORTS, 2005, 57 (06) : 795 - 801
  • [5] Therapeutic potential of non-competitive, subtype-selective metabotropic glutamate receptor ligands
    Mutel, V
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2002, 12 (12) : 1845 - 1852
  • [6] Pharmacological profile of perampanel: a novel, non-competitive selective AMPA receptor antagonist
    Tokuhara, N.
    Hatakeyama, S.
    Amino, H.
    Hanada, T.
    Nishizawa, Y.
    JOURNAL OF NEUROLOGY, 2008, 255 : 175 - 175
  • [7] Pharmacological profile of perampanel : A novel, non-competitive selective AMPA receptor antagonist
    Tokuhara, Naoki
    Hatakeyama, Shinji
    Amino, Hiroyuki
    Hanada, Takahisa
    Nishizawa, Yukio
    NEUROLOGY, 2008, 70 (11) : A78 - A78
  • [8] Pharmacological profile of the group-I non-competitive antagonist, CPCCOEt, on CHO cell lines and rat cerebellar granule cells
    Cavanni, P
    Bonomo, F
    Faedo, S
    Salvagno, C
    Corsi, M
    NEUROPHARMACOLOGY, 1999, 38 (10) : A10 - A11
  • [9] Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonists
    Milbank, Jared B. J.
    Knauer, Christopher S.
    Augelli-Szafran, Corinne E.
    Sakkab-Tan, Annette T.
    Yamagata, Kristin K. Lin Koji
    Hoffman, Jennifer K.
    Thomas, Nian Zhuang John
    Galatsis, Paul
    Mickelson, John A. Wendt John W.
    Schwarz, Roy D.
    Kinsora, Jack J.
    Lotarski, Susan M.
    Stakich, Korana
    Gillespie, Kristen K.
    Lam, Wing W.
    Mutlib, Abdul E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) : 4415 - 4418
  • [10] Discovery and characterization of non-competitive antagonists of group I metabotropic glutamate receptors
    Gasparini, F
    Floersheim, P
    Flor, PJ
    Heinrich, M
    Inderbitzin, W
    Ott, D
    Pagano, A
    Stierlin, C
    Stoehr, N
    Vranesic, I
    Kuhn, R
    FARMACO, 2001, 56 (1-2): : 95 - 99